A Large Gene Network in Immature Erythroid Cells Is Controlled by the Myeloid and B Cell Transcriptional Regulator PU.1
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
PU.1 is a hematopoietic transcription factor that is required for the development of myeloid and B cells. PU.1 is also expressed in erythroid progenitors, where it blocks erythroid differentiation by binding to and inhibiting the main erythroid promoting factor, GATA-1. However, other mechanisms by which PU.1 affects the fate of erythroid progenitors have not been thoroughly explored. Here, we used ChIP-Seq analysis for PU.1 and gene expression profiling in erythroid cells to show that PU.1 regulates an extensive network of genes that constitute major pathways for controlling growth and survival of immature erythroid cells. By analyzing fetal liver erythroid progenitors from mice with low PU.1 expression, we also show that the earliest erythroid committed cells are dramatically reduced in vivo. Furthermore, we find that PU.1 also regulates many of the same genes and pathways in other blood cells, leading us to propose that PU.1 is a multifaceted factor with overlapping, as well as distinct, functions in several hematopoietic lineages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 PU.1 occupies many of the same gene targets in myeloid and erythroid cells, and PU.1-dependent gene regulation is similar in HSC, myeloid, and erythroid cells. (A) qChIP was performed for PU.1 as described in Materials and Methods with chromatin from 32D cells using primers described in Table S2. An HA antibody was used as an isotype control. The same primers were used to show that PU.1 binds close to these genes in MEL cells and ES-EP (Figure S5). The myogenin gene serves as a negative control. Standard deviations were calculated from triplicate PCR reactions. Similar results were obtained with at least two independent chromatin preparations. (B) Expression data from PU.1−/− cells stimulated to differentiate into macrophages by the restoration of PU.1 [49] and HSC from PU.1 knockdown mice [33] were used to compare with PU.1 dependent gene regulation in early erythroid progenitors from PU.1 knockdown mice. Of the PU.1 bound genes in MEL and ES-EP that displayed a ≥1.5-fold change in expression, 308 were upregulated and 209 were downregulated. 162 and 265 of these PU.1 dependent genes were annotated in the other 2 datasets. Venn diagrams display the comparisons between the three datasets of these upregulated genes (left) and downregulated genes (right).](https://figures.cochat.ai/paper-figures/4b1f91b96d2545fbbc39337e22408a3b/a-large-gene-network-in-immature-erythroid-cells-is-controlled-by-the-myeloid-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Overall, CellOracle accurately simulated the myeloid lineage switching governed by Gata1 and Spi1 (refs. 15,25–27; Fig. 1g), including a relatively mild Gata1 KO phenotype in early granulocyte differentiation (Fig. 1h), which cannot be inferred from the low levels of Gata1 expression in granulocytes (Extended Data Fig. 3d).”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [27]
In the citing paper
“However, CellOracle did not detect a previously reported depletion of erythrocyte progenitors after Spi1 KO27,28, probably owing to changes in cell proliferation that are not predicted by the method.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · cited 23×
“Peaks were further annotated by their genomic locations with respect to current gene annotation ( right ) and classified as proximal promoter ( + / 22 kb of TSS ) , 39 end of gene ( + / 22 kb of TES ) , gene body ( between +2 kb of TSS and 22 kb of TES ) , miRNA promoters , or otherwise intergenic regions .”
BackgroundResultInfluentialFitting a mixture model by expectation maximization to discover motifs in biopolymers.
Bailey, T. L., & Elkan, C. (1994) · PubMed · Cited by 5,806
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Orkin, S. H., & Zon, L. I. (2008) · Cell · doi:10.1016/j.cell.2008.01.025 · Cited by 2,570 · cited 1×
“In addition to promoting their lineage-specific gene expression programs, these factors may also inhibit the transcriptional programs of alternative cell lineages [1].”
BackgroundTRANSFAC(R) and its module TRANSCompel(R): transcriptional gene regulation in eukaryotes
Matys, V. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj143 · Cited by 2,166 · cited 1×
“and also known motifs in the TRANSFAC software suit (release 11)”
BackgroundRequirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 6×
“1 is a master regulatory transcription factor that plays an essential role in the development of the myeloid and B-cell lineages [4,5].”
BackgroundInfluentialPevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S.-F., D'Agati, V., Orkin, S. H., & Costantini, F. (1991) · Nature · doi:10.1038/349257a0 · Cited by 1,308 · cited 1×
“GATA-1 is a Zn-finger DNA binding protein that is required for the development of erythrocytes and megakaryocytes [6].”
BackgroundJak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156 · cited 1×
“These pathways include the PI3K/Akt, ERK/ MAPK, and Jak/Stat pathways (Figure 5 and data not shown), all of which have been implicated in survival and proliferation of erythroid progenitors [61–64].”
BackgroundTargeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 6×
“1 is a master regulatory transcription factor that plays an essential role in the development of the myeloid and B-cell lineages [4,5].”
BackgroundInfluentialWu, H., Liu, X., Jaenisch, R., & Lodish, H. F. (1995) · Cell · doi:10.1016/0092-8674(95)90234-1 · Cited by 1,017 · cited 1×
“1, inhibit erythroid differentiation, whereas Gfi-1b [38], the erythropoietin receptor (EpoR) [39], and the erythroid kruppel-like factor Klf1 [40,41] promote erythroid differentiation.”
BackgroundThe macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · cited 1×
“1 binding sites [27,28] and matching the known binding sequence of the Ets family of transcription factors [19].”
Background
Cited by
Dissecting cell identity via network inference and in silico gene perturbation
Kamimoto, K., Stringa, B., Hoffmann, C. M., Jindal, K., Solnica-Krezel, L., & Morris, S. A. (2023) · Nature · doi:10.1038/s41586-022-05688-9 · Cited by 677
Yang, S.-M., Kim, B. J., Toro, L. N., & Skoultchi, A. I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213266110 · Cited by 141
“U ni ts (x 10 -3 ) WT TKO H1d(1-159) R-5 H1d(1-159) R-26 A H19 Gtl2 Rian Mirg”
Self-citationWill, B., Vogler, T. O., Bartholdy, B., Garrett-Bakelman, F., Mayer, J., Barreyro, L., Pandolfi, A., Todorova, T. I., Okoye-Okafor, U. C., Stanley, R. F., et al. (2013) · Nature Immunology · doi:10.1038/ni.2572 · Cited by 105
Self-citationMechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1
Pham, T.-H., Minderjahn, J., Schmidl, C., Hoffmeister, H., Schmidhofer, S., Chen, W., Längst, G., Benner, C., & Rehli, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt355 · Cited by 102
“1binding sites in mouse lymphoid and myeloid progenitor cells (12,13), mouse macrophages or B cells (8,14), murine reticulocytes (15,16), as well as in human monocytes and macrophages (7).”
Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development
Rothenberg, E. V., Hosokawa, H., & Ungerbäck, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00228 · Cited by 99
Song, H. K., Hong, S.-E., Kim, T., & Kim, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035552 · Cited by 95
“1 ChIP-Seq peaks are abundant within the upstream regions of cell cycle regulators in erythroid cells [20], the specific roles of PU.”
BackgroundArchitecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3
Del Real, M. M., & Rothenberg, E. V. (2013) · Development · doi:10.1242/dev.088559 · Cited by 95
“However, it is also required for the development and function of other cell types, including hematopoietic stem cells (Iwasaki et al., 2005), multipotent progenitors (Wontakal et al., 2011), myeloid cells (Ghani et al., 2011) and B cells (Houston et al., 2007).”
BackgroundLi, L., Freudenberg, J., Cui, K., Dale, R., Song, S.-H., Dean, A., Zhao, K., Jothi, R., & Love, P. E. (2013) · Blood · doi:10.1182/blood-2013-01-479451 · Cited by 90
May, G., Soneji, S., Tipping, A. J., Teles, J., McGowan, S. J., Wu, M., Guo, Y., Fugazza, C., Brown, J., Karlsson, G., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.09.003 · Cited by 88
“1 (Wontakal et al., 2011); the observation that much of the binding originates in MPCs provides a developmental context.”
BackgroundWontakal, S. N., Guo, X., Smith, C., MacCarthy, T., Bresnick, E. H., Bergman, A., Snyder, M. P., Weissman, S. M., Zheng, D., & Skoultchi, A. I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121019109 · Cited by 79
“We also find that the genes co-occupied by GATA-1, SCL, and Klf1 exhibit the largest changes in gene expression during the differentiation of both ES-EP and MEL cells (Fig.”
BackgroundMethodInfluentialSelf-citationChamphekar, A., Damle, S. S., Freedman, G., Carotta, S., Nutt, S. L., & Rothenberg, E. V. (2015) · Genes & Development · doi:10.1101/gad.259879.115 · Cited by 74
“…to tens of thousands of genomic sites, which differ in erythroidcells,myeloidcells,Bcells, andearlyTcells (Ghisletti et al. 2010; Heinz et al. 2010; Wontakal et al. 2011, 2012;Ridinger-Saisonet al. 2012;Zhanget al. 2012;Ostuni et al. 2013), but in all of these cases, the majority of the binding…”
BackgroundLong and Short Non-Coding RNAs as Regulators of Hematopoietic Differentiation
Morceau, F., Chateauvieux, S., Gaigneaux, A., Dicato, M. A., & Diederich, M. F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714744 · Cited by 81
“1, a member of the Ets(E-twenty six) TF family, is involved in differentiation from HSCs to multipotent progenitors at different levels [58].”
BackgroundEpigenetic program and transcription factor circuitry of dendritic cell development
Lin, Q., Chauvistré, H., Costa, I. G., Gusmao, E. G., Mitzka, S., Hänzelmann, S., Baying, B., Klisch, T., Moriggl, R., Hennuy, B., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1056 · Cited by 77
Curik, N., Burda, P., Vargová, K., Pospíšil, V., Beličková, M., Vlckova, P., Savvulidi, F. G., Nečas, E., Hajkova, H., Haškovec, C., et al. (2012) · Leukemia · doi:10.1038/leu.2012.47 · Cited by 48
Yu, Y., Mo, Y., Ebenezer, D., Bhattacharyya, S., Liu, H., Sundaravel, S., Giricz, O., Wontakal, S., Cartier, J., Caces, B., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423756 · Cited by 43
Self-citationGenome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line
Solomon, L. A., Li, S. K. H., Piskorz, J., Xu, L., & DeKoter, R. P. (2015) · BMC Genomics · doi:10.1186/s12864-015-1303-0 · Cited by 47
Sheffield, N. C., & Furey, T. S. (2012) · Genes · doi:10.3390/genes3040651 · Cited by 47
Machherndl‐Spandl, S., Suessner, S., Danzer, M., Proell, J., Gabriel, C., Lauf, J., Sylie, R., Klein, H.-U., Béné, M. C., Weltermann, A., et al. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2012.45 · Cited by 37
He, J., Wen, W., Beeghly, A., Chen, Z., Cao, C., Shu, X., Zheng, W., Long, Q., & Guo, X. (2022) · Nature Communications · doi:10.1038/s41467-022-34888-0 · Cited by 38
“1B; Supplementary Data 2; Methods).”
BackgroundMethodInfluentialSelf-citationIntegrating novel signaling pathways involved in erythropoiesis
Ingley, E. (2012) · IUBMB Life · doi:10.1002/iub.1024 · Cited by 36
Sun, H., Guns, T., Fierro, A. C., Thorrez, L., Nijssen, S., & Marchal, K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks237 · Cited by 38
“Supplementary Data are available at NAR Online: Supplementary Tables S1–S3, Supplementary Figures S1–S2 and Supplementary References [62–112].”
Role of transcriptional corepressor ETO2 in erythroid cells
Fujiwara, T., Alqadi, Y. W., Okitsu, Y., Fukuhara, N., Onishi, Y., Ishizawa, K., & Harigae, H. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.10.015 · Cited by 36
“1, is also known as a negative regulator of erythroid progenitors [26–28].”
BackgroundSenescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells
Delestré, L., Cui, H., Esposito, M., Quiveron, C., Mylonas, E., Penard-Lacronique, V., Bischof, O., & Guillouf, C. (2017) · Haematologica · doi:10.3324/haematol.2016.157636 · Cited by 32
“It acts by controlling the expression of a subset of lineage-specific genes involved in hematopoiesis(6) and the expression of ubiquitous cell cycle regulators.(5,7,8)”
BackgroundConcise Review: Production of Cultured Red Blood Cells from Stem Cells
Bouhassira, E. E. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0097 · Cited by 34
Spi-1/PU.1 activates transcription through clustered DNA occupancy in erythroleukemia
Ridinger-Saison, M., Boeva, V., Rimmelé, P., Kulakovskiy, I., Gallais, I., Levavasseur, B., Paccard, C., Legoix-Né, P., Morlé, F., Nicolas, A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks659 · Cited by 28
“We compared the Spi-1 genomic occupancy in the MEL erythroleukemic cells (23) and in the erythroleukemic cells derived from spi-1 transgenic mice (this study).”
BackgroundGregoricchio, S., Polit, L., Esposito, M., Berthelet, J., Delestré, L., Evanno, E., Diop, M., Gallais, I., Aleth, H., Poplineau, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac613 · Cited by 27
“SPI1, interacting with GATA1 (26,27), creates a repressive histone context at GATA1 binding sites (28–30) or represses expression of GATA1 co-factors (31).”
BackgroundWillcockson, M. A., Taylor, S. J., Ghosh, S., Healton, S. E., Wheat, J. C., Wilson, T. J., Steidl, U. G., & Skoultchi, A. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901122116 · Cited by 26
“1 levels have reduced numbers of erythroid progenitors (7), and Pu.”
BackgroundResultSelf-citationTaylor, S. J., Stauber, J., Bohorquez, O., Tatsumi, G., Kumari, R., Chakraborty, J., Bartholdy, B. A., Schwenger, E., Sundaravel, S., Farahat, A. A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01911-7 · Cited by 22
“CUT&Tag identified 34,904 total PU.1 binding sites, consistent with the number of PU.1 peaks found in prior localization studies 28–30 , with 19% of sites being lost and 15% being gained following DB2115 exposure ( n = 3, Diffbind false discovery rate (FDR) < 0.1; Fig.”
InfluentialSelf-citationDNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation
Fernández-Nestosa, M. J., Monturus, E., Sánchez, Z., Torres, F. S., Fernández, A. F., Fraga, M. F., Hernández, P., Schvartzman, J. B., & Krimer, D. B. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-392 · Cited by 20
PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1
Ziliotto, R. G., Gruca, M. R., Podder, S., Noel, G., Ogle, C. K., Hess, D. A., & DeKoter, R. P. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.11.011 · Cited by 16
“1 was shown to bind directly to the E2f1 promoter during erythroid differentiation [44].”
BackgroundGATA1 and PU.1 Bind to Ribosomal Protein Genes in Erythroid Cells: Implications for Ribosomopathies
Amanatiadou, E. P., Papadopoulos, G. L., Strouboulis, J., & Vizirianakis, I. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140077 · Cited by 17
“1 binding profiles by ChIPseq to the RPS19 gene locus in two independent experiments (A or B) using differentiated MEL cells or mES-EPs [39].”
BackgroundMethodInfluentialAoyama, S., Nakano, H., Danbara, M., Higashihara, M., Harigae, H., & Takahashi, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.071 · Cited by 14
He, G., Tolic, A., Bashkin, J. K., & Poon, G. M. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv267 · Cited by 18
“Increasing awareness that co-expressing ETS members regulate distinct genetic networks in vivo (41–45) highlights the need for understanding how structurally homologous ETS proteins resolve their overlapping DNA sequence preferences.”
BackgroundKorczmar, E., Bookstaver, A. K., Ober, E., Goldfarb, A. N., Tenen, D. G., & Trinh, B. Q. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1602010 · Cited by 9
“Similarly, low levels of PU.1 promote the proliferation of early erythroid progenitors, yet complete suppression is required for their terminal differentiation [28– 32].”
BackgroundPing, J., Liu, X., Lu, Y., Quan, C., Fan, P., Lu, H., Li, Q., Wang, C., Zhang, Z., Liu, M., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100782 · Cited by 9
Zhang, S., Wu, G., Shi, L., Ding, P., Liu, G., Chang, W., Dai, Y., Han, X., & Ma, X. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000738 · Cited by 9
“[37,38] Previous studies have shown that SPI1 mutations can lead to immune cell-associated cancers, playing a crucial role in acute myelocytic leukemia progression, with reduced PU.1 levels observed in human acute myelocytic leukemia cases.”
Qiu, K., Vu, D. C., Wang, L., Nguyen, N. N., Bookstaver, A. K., Sol‐Church, K., Li, H., Dinh, T. N., Goldfarb, A. N., Tenen, D. G., et al. (2024) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00556-4 · Cited by 7
“Lower expression is needed for B cells [9], and trace levels of PU.1 are required for the proliferation of erythroid progenitors [10–12].”
BackgroundPU.1 negatively regulates tumorigenesis in non-small-cell lung cancer
Liu, X., Xu, M., Jia, W., Duan, Y., Ma, J., & Tai, W. (2023) · Medical Oncology · doi:10.1007/s12032-023-01946-6 · Cited by 7
Chen, Z., Song, W., Li, Q., Li, C., Wen, W., Huyghe, J. R., Law, P. J., Fernández–Rozadilla, C., Timofeeva, M. N., Thomas, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68127-z · Cited by 4
“Key TFs transcribed in a cell type-speci fi c manner and co-occupy cis-regulatory elements that control gene expression programs to establish and maintain cell identity 25 – 29 .”
Self-citationNakano, H., YANAGITA, A., & Takahashi, S. (2014) · Biomedical Reports · doi:10.3892/br.2014.265 · Cited by 2
“…progenitors from mice, which are used for analyzing the embryonic-fetal stages, whereas MEL cells are considered to be a model for fetal-adult development (20), which are employed in the majority of the previous studies analyzing the functions of PU.1 during erythroid differentiation (6,16,17).”
Batista, C. R., & DeKoter, R. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101960 · Cited by 2
Myelopoiesis specific gene expression profiling in human CD34+ hematopoietic stem cells
Joshi, M., & Gangenahalli, G. U. (2020) · Gene Expression Patterns · doi:10.1016/j.gep.2020.119128 · Cited by 1
Qiu, K., Vu, D., Wang, L., Bookstaver, A. K., Dinh, T. N., Goldfarb, A. N., Tenen, D. G., & Trinh, B. Q. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.01.573782 · Cited by 1
Genome-Scale Technology Driven Advances to Research into Normal and Malignant Haematopoiesis
Göttgens, B. (2012) · Scientifica · doi:10.6064/2012/437956
Real, D. (2013) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/pews-km18
Wickrema, A., Verma, A. K., Godley, L. A., Skoultchi, A., Greally, J. M., Gligich, O., Suzuki, M., Steidl, U. G., Bathon, K., Maqbool, S. B., et al. (2013)
Self-citationJothi, R., Love, P. E., Freudenberg, J., Cui, K., Dale, R., & Zhao, K. (2014)
Gene Repression and Cell Cycle Regulation by PU.1 in Acute Myeloid Leukemia
Ziliotto, R. G. (2013) · Scholarship@Western (Western University)
Batista, C. R., & DeKoter, R. P. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101960-1
An oracle predicts regulators of cell identity
Farrell, J. A. (2023) · Nature · doi:10.1038/d41586-023-00251-6
Etude du récepteur à la transferrine de type 2 dans l'érythropoïese.
Richard, C. (2019) · theses.fr (ABES) · doi:10.70675/c36ec54fz3a93z404cz8641z05a8f1db21d5
Plasmodium falciparum provoque des altérations importantes de la différenciation érythroïde
Dumarchey, A. (2024) · theses.fr (ABES) · doi:10.70675/8af66127zddb6z4a8fz9f0ez6c0d126269bc
Metadata
- Authors
- Wontakal, S. N., Guo, X., Will, B., Shi, M., Raha, D., Mahajan, M. C., Weissman, S., Snyder, M., Steidl, U., Zheng, D., & Skoultchi, A. I.
- Affiliations
- Albert Einstein College of Medicine (US)
- Yale University (US)
- Corresponding author
- Zheng, Deyou
- Skoultchi, Arthur I.
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-06-09
- Volume
- 7
- Issue
- 6
- Pages
- e1001392
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3111485
- OpenAlex
- W1975400920
- Cited by
- 53
- References
- 75
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 2 · 2020: 1 · 2019: 3 · 2017: 2 · 2016: 1 · 2015: 5 · 2014: 2 · 2013: 14 · 2012: 12
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Yeshiva University
- National Institutes of Health
- Albert Einstein College of Medicine, Yeshiva University
- National Heart, Lung, and Blood Institute (R01HL078381)
- National Eye Institute (EY012200, R01EY012200)
- National Cancer Institute (2P30-CA13330, R01CA166429, HL078381/CA154239, R00CA131503, P30CA013330)
- National Institute of General Medical Sciences (5T32GM07288, T32GM007288)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- PU.1, erythroid progenitor cells, erythroid differentiation, GATA-1, hematopoietic transcription factors, gene regulatory networks, myeloid development, B cell development
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Cell Differentiation, Cell Line, Proto-Oncogene Proteins, Transcription, Genetic, Trans-Activators, Erythroid Precursor Cells, Cell Lineage, Chromatin Immunoprecipitation, Mice, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.